Mode of action of iron on arylsulphatases under acute lead acetate treated conditions in rats.
Arylsulphatases A, B and C were found to be inhibited in liver and kidney tissues under lead acetate-treated conditions (both in vivo and in vitro) in rats. When lead acetate-treated animals (in vivo) were supplemented with ferric ammonium citrate (in vivo), a remarkable recovery was found in the activities of all arylsulphatases A, B and C whereas ferric ammonium citrate itself had no effect on the activities of arylsulphatases. When both the in vivo and in vitro lead acetate-treated arylsulphatases were supplemented with the purified ferritins (in vitro) it was observed that lead-induced inhibition of the activities of arylsulphatases was successfully reversed. It was also found that ferritins were able to bind a large quantity of lead. These results indicated that ferritins were directly involved for reactivation of arylsulphatases which were inhibited by lead. It was well established that a response to iron administration in rats was an immediate de novo stimulation of ferritin biosynthesis. Iron might therefore protect the enzymatic activities of arylsulphatases by enhancing the level of ferritin in liver and kidney tissues which is known to bind a large quantity of lead thereby ameliorating their toxic effects in the living system.
M
M
Santra
A
A
Basu
G C
GC
Chatterjee
D000818:Animals; D001192:Arylsulfatases / Q000378:metabolism*; D007501:Iron / Q000502:physiology*; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D009942:Organometallic Compounds / Q000633:toxicity*; D051381:Rats; D013429:Sulfatases / Q000378:metabolism*
D009942:Organometallic Compounds; D007501:Iron; D013429:Sulfatases; D001192:Arylsulfatases; C008261:lead acetate